DKDimitrios Kyriakou

Dimitrios Kyriakou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dimitrios Kyriakou has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Screening and Diagnosis Imagery in Breast Cancer: Classical and Emergent Techniques

    by Georgios Iatrakis, Stefanos Zervoudis, Anastasia Bothou, Eftymios Oikonomou, Konstantinos Nikolettos, Kyriakou Dimitrios, Nalmpanti Athanasia-Theopi, Kritsotaki Nektaria, Kotanidou Sonia, Spanakis Vlasios, et al.

    In light of the limitations of mammography, ultrasound, and breast MRI, some other breast imaging techniques have recently been investigated to reduce false positive rates and raise breast cancer detection including (1) digital breast tomosynthesis, (2) bilateral contrast-enhanced dual-energy digital mammography, (3) ultrasound elastography, (4) abbreviated breast MRI, (5) magnetic resonance spectroscopy, and (6) ductoscopy and duct cytology. The purpose of this review was to examine the advantages and disadvantages of these six different breast cancer imaging techniques.


  • Open Access

    The Impact of Periodontal Disease on Preterm Birth and Preeclampsia

    by Panagiotis Tsikouras, Efthymios Oikonomou, Konstantinos Nikolettos, Sotiris Andreou, Dimitrios Kyriakou, Christos Damaskos, Nikolaos Garmpis, Vassiliki Monastiridou, Theopi Nalmpanti, Anastasia Bothou, et al.

    This review delves into the possible connection between periodontitis and negative pregnancy outcomes, such as preeclampsia and preterm birth. It highlights the potential influence of an unidentified microbial factor on preeclampsia and the effects of inflammatory responses on the rate of preterm births. Furthermore, it underscores the prevalent occurrence of oral ailments within the populace and their significant repercussions on quality of life. Hormonal fluctuations during pregnancy may exacerbate oral conditions such as pregnancy gingivitis and periodontitis, necessitating bespoke therapeutic approaches that take into account potential fetal ramifications. Periodontal disease, characterized by microbial attack and inflammatory response, results in tissue destruction and tooth loss. The oral cavity’s susceptibility to bacterial colonization, which is primarily due to its role as a site for food intake, is highlighted. Furthermore, research indicates a correlation between inflammatory responses and factors such as prostaglandin E2 and IL-1β, and preterm birth. Therapeutic interventions are a focus of international research, with efforts being aimed at optimizing outcomes through larger studies involving pregnant women.


  • Open Access

    The Impact of Endometriosis on Pregnancy

    by Panagiotis Tsikouras, Efthimios Oikonomou, Anastasia Bothou, Penelopi Chaitidou, Dimitrios Kyriakou, Konstantinos Nikolettos, Sotirios Andreou, Foteini Gaitatzi, Theopi Nalbanti, Panagiotis Peitsidis, et al.

    Despite the increased frequency of endometriosis, it remains one of the most enigmatic disorders regarding its effects on pregnancy. Endometriosis adversely affects both natural and assisted conception. Impaired folliculogenesis, which causes follicular dysfunction and low egg quality, as well as luteal phase problems, reduced fertilization, and abnormal embryogenesis, are some of the mechanisms advocated to explain reproductive dysfunction. There is a rising need for a comprehensive study of the potential negative consequences of this condition on pregnancy outcomes, including the postpartum period, as more women with a medical history of endometriosis become pregnant. Obstetrical complications (small for gestational age [SGA], cesarean section [CS], miscarriage, hemorrhage, low placental adhesion, and preterm delivery) are statistically elevated in women with endometriosis. Furthermore, ruptured ovarian endometrioma, appendicitis, intestinal perforation, and hemoperitoneum have been described in pregnancy. Obstetricians are largely unfamiliar with these complications, as they have not been thoroughly investigated. The development and pathogenesis of endometriosis is an important field of study and has not yet been fully elucidated. Finding these mechanisms is crucial for the development of new and more effective strategies to treat this condition. Endometriosis can have an impact on obstetric and neonatal outcomes of pregnancy, in addition to its potential effects on conception. To date, no additional monitoring is recommended for pregnancies with a history of endometriosis. However, more studies are urgently needed to assess the need for the tailored pregnancy monitoring of women with endometriosis.


  • Open Access

    The Contribution of Isoflavones in Menopausal Symptomatic as Alternative Treatment Option

    by Panagiotis Tsikouras, Anna Chalkidou, Georgios Iatrakis, Efthimios Oikonomou, Anastasia Bothou, Dimitrios Kyriakou, Aise Chatzi Ismail Mouchterem, Alexios Alexiou, Konstantinos Nikolettos, Nektaria Kritsotaki, et al.

    Menopause should be treated as a state of alteration of estrogen metabolism. It is characterized by a decrease in progesterone and an increase in estrogen followed by a drop in estrogen. The purpose of this study is to investigate the activity of hyaluronic acid 120 mg and isoflavones MF11RCE 80 mg, in the recovery of the symptoms of menopause and the treatment of its secondary complications such as osteoporosis, urogenital atrophy and accompanying urinary incontinence and vasomotor syndrome MF11RCE isoflavones are widely used to treat various disorders related mainly to women’s health and mainly osteoporosis and menopausal discomforts, based on epidemiological studies that brought the above diseases to a lower percentage, in populations with a high consumption of these plant estrogens. Isoflavones are derived from plants and structurally or functionally resemble endogenous-natural estrogens and their active metabolites. Therefore, they have significant estrogenic (agonistic/antagonistic) activity.


  • Open Access

    Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years

    by Panagiotis Tsikouras, Efthymios Oikonomou, George Tsatsaris, Anastasia Bothou, Dimitrios Kyriakou, Konstantinos Nikolettos, Theopi Nalmbanti, Panagiotis Peitsidis, Grigorios Trypsanis, George Iatrakis, et al.

    Uterine artery embolization (UAE) for the treatment of symptomatic uterine fibroids and non-controllable adenomyosis symptoms is a relatively new procedure for organ-preserving therapy. These benign conditions can become symptomatic in about 30% of women between the ages of 35 and 50. The purpose of the UAE either for fibroids or adenomyosis is the elimination of blood loss, the reduction in pain, and bulky or rectal pressure symptoms. The purpose of this study is to present our experience in UAE with the use of hydrogel-coated tris acryl microspheres for the treatment of symptomatic uterine fibroids and adenomyosis.